Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane affects the expression of TNFSF11 mRNA | affects expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TNFSF11 mRNA | affects expression | 16483693
|
D000677 |
Amsacrine |
Amsacrine results in decreased expression of TNFSF11 mRNA | decreases expression | 11459812
|
D001151 |
Arsenic |
[Arsenic co-treated with Fluorides] results in decreased expression of TNFSF11 mRNA | affects cotreatment|decreases expression | 19962721
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of TNFSF11 mRNA | decreases expression | 17530438
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA] | decreases reaction|increases expression | 17306214
|
D003345 |
Corticosterone |
[Corticosterone co-treated with PTH protein] results in decreased expression of TNFSF11 mRNA | affects cotreatment|decreases expression | 17476578
|
D003345 |
Corticosterone |
Corticosterone results in increased expression of TNFSF11 mRNA | increases expression | 17476578
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [TNFSF11 protein results in increased activity of CHUK protein] | decreases reaction|increases activity | 15129424
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [TNFSF11 protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15129424
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [IL1A protein results in increased expression of TNFSF11 protein] | decreases reaction|increases expression | 18719352
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TNFSF11 mRNA] | decreases expression|decreases reaction | 11007951
|
C014347 |
decitabine |
decitabine promotes the reaction [Cholecalciferol results in increased expression of TNFSF11 mRNA] | increases expression|increases reaction | 17008384
|
C014347 |
decitabine |
decitabine results in increased expression of TNFSF11 mRNA | increases expression | 17008384
|
D003907 |
Dexamethasone |
[Thalidomide co-treated with Dexamethasone] results in decreased expression of TNFSF11 protein | affects cotreatment|decreases expression | 16079895
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of TNFSF11 mRNA | increases expression | 17293108
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of TNFSF11 mRNA | increases expression | 16813520 11113387
|
D002117 |
Calcitriol |
menatetrenone inhibits the reaction [Calcitriol results in increased expression of TNFSF11 mRNA] | decreases reaction|increases expression | 11113387
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of TNFSF11 mRNA | increases expression | 17352647
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of TNFSF11 protein | increases expression | 17352647
|
D004144 |
Diosgenin |
Diosgenin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] | decreases reaction|increases expression | 16331273
|
D004144 |
Diosgenin |
Diosgenin results in decreased activity of TNFSF11 protein | decreases activity | 16331273
|
D004958 |
Estradiol |
Estradiol results in increased expression of TNFSF11 mRNA | increases expression | 19401787
|
D004967 |
Estrogens |
Estrogens results in decreased expression of TNFSF11 mRNA | decreases expression | 16005483
|
D005047 |
Etoposide |
Etoposide results in decreased expression of TNFSF11 mRNA | decreases expression | 11459812
|
C074031 |
exenatide |
exenatide results in decreased expression of TNFSF11 mRNA | decreases expression | 19586609
|
D005459 |
Fluorides |
[Arsenic co-treated with Fluorides] results in decreased expression of TNFSF11 mRNA | affects cotreatment|decreases expression | 19962721
|
D005665 |
Furosemide |
Furosemide affects the expression of TNFSF11 mRNA | affects expression | 17497460
|
D019833 |
Genistein |
Genistein results in decreased expression of TNFSF11 mRNA | decreases expression | 11459812
|
D019833 |
Genistein |
Genistein results in increased expression of TNFSF11 mRNA | increases expression | 19401787
|
D019812 |
Heparan Sulfate Proteoglycans |
[Heparan Sulfate Proteoglycans binds to and results in increased activity of FGF2 protein] which results in increased expression of TNFSF11 protein | affects binding|increases activity|increases expression | 15334457
|
C056599 |
icariin |
icariin results in decreased expression of TNFSF11 mRNA | decreases expression | 19747809
|
C056599 |
icariin |
NOG protein inhibits the reaction [icariin results in decreased expression of TNFSF11 mRNA] | decreases expression|decreases reaction | 19747809
|
C513449 |
icarisid II |
icarisid II results in decreased expression of TNFSF11 mRNA | decreases expression | 17764702
|
C499403 |
icaritin |
icaritin results in decreased expression of TNFSF11 mRNA | decreases expression | 17764702
|
C006552 |
kaempferol |
kaempferol inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] | decreases reaction|increases expression | 16434028
|
C006552 |
kaempferol |
kaempferol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA] | decreases reaction|increases expression | 16434028
|
C006552 |
kaempferol |
kaempferol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA] | decreases reaction|increases expression | 16434028
|
C030814 |
menatetrenone |
menatetrenone inhibits the reaction [Calcitriol results in increased expression of TNFSF11 mRNA] | decreases reaction|increases expression | 11113387
|
D016912 |
Levonorgestrel |
Levonorgestrel results in decreased expression of TNFSF11 mRNA | decreases expression | 16114553
|
C010722 |
nylestriol |
nylestriol results in decreased expression of TNFSF11 mRNA | decreases expression | 16114553
|
C034364 |
ozagrel |
ozagrel results in decreased expression of TNFSF11 mRNA | decreases expression | 18264100
|
C084656 |
paricalcitol |
paricalcitol results in increased expression of TNFSF11 mRNA | increases expression | 17352647
|
C084656 |
paricalcitol |
paricalcitol results in increased expression of TNFSF11 protein | increases expression | 17352647
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA] | decreases reaction|increases expression | 17306214
|
D010424 |
Pentobarbital |
Pentobarbital results in decreased expression of TNFSF11 mRNA | decreases expression | 16978161
|
D010656 |
Phenylephrine |
bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA] | decreases reaction|increases expression | 17306214
|
D010656 |
Phenylephrine |
PD 98059 inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA] | decreases reaction|increases expression | 17306214
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of TNFSF11 mRNA | increases expression | 17306214
|
D010656 |
Phenylephrine |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA] | decreases reaction|increases expression | 17306214
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TNFSF11 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C025299 |
polyphenols |
polyphenols results in decreased expression of TNFSF11 mRNA | decreases expression | 16293270
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Phenylephrine results in increased expression of TNFSF11 mRNA] | decreases reaction|increases expression | 17306214
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] | decreases reaction|increases expression | 16434028 19495926
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA] | decreases reaction|increases expression | 19495926
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA] | decreases reaction|increases expression | 16434028
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA] | decreases reaction|increases expression | 19495926
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | decreases reaction|increases expression | 19495926
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA] | decreases reaction|increases expression | 16434028
|
D011794 |
Quercetin |
Quercetin results in decreased activity of TNFSF11 protein | decreases activity | 19495926
|
C443401 |
quercetin 3-O-glucuronide |
quercetin 3-O-glucuronide results in decreased activity of TNFSF11 protein | decreases activity | 19495926
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of TNFSF11 mRNA | decreases expression | 16005483
|
C059514 |
resveratrol |
[resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CD14 mRNA | affects cotreatment|increases expression | 16267019
|
C059514 |
resveratrol |
[resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CSF1R mRNA | affects cotreatment|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ITGAL mRNA] | affects cotreatment|decreases expression|decreases reaction | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein] | affects cotreatment|decreases reaction|increases activity | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TNFRSF11A mRNA] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TNFRSF11A protein] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased localization of RELA protein] | affects cotreatment|decreases reaction|increases localization | 16267019
|
C059514 |
resveratrol |
resveratrol results in increased expression of TNFSF11 mRNA | increases expression | 16813520
|
C084904 |
Ro 41-5253 |
Ro 41-5253 inhibits the reaction [Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | decreases reaction|increases expression | 17291456
|
C084904 |
Ro 41-5253 |
Ro 41-5253 inhibits the reaction [tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | decreases reaction|increases expression | 17291456
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TNFSF11 mRNA | decreases expression | 16014739
|
C099410 |
TAPI-2 |
TAPI-2 inhibits the reaction [zoledronic acid results in decreased expression of TNFSF11 protein] | decreases expression|decreases reaction | 14753746
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TNFSF11 mRNA] | decreases expression|decreases reaction | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TNFSF11 mRNA | decreases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TNFSF11 mRNA | increases expression | 15972635 15310856
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of TNFSF11 mRNA | increases expression | 17306214
|
D013792 |
Thalidomide |
[Thalidomide co-treated with Dexamethasone] results in decreased expression of TNFSF11 protein | affects cotreatment|decreases expression | 16079895
|
C024587 |
thromboxane A2, carbocyclic |
thromboxane A2, carbocyclic results in increased expression of TNFSF11 mRNA | increases expression | 18264100
|
D014212 |
Tretinoin |
Ro 41-5253 inhibits the reaction [Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | decreases reaction|increases expression | 17291456
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | decreases reaction|increases expression | 17291456
|
C011559 |
tributyltin |
Ro 41-5253 inhibits the reaction [tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | decreases reaction|increases expression | 17291456
|
C011559 |
tributyltin |
tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | decreases reaction|increases expression | 17291456
|
C030665 |
triphenyltin |
triphenyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | decreases reaction|increases expression | 17291456
|
C057693 |
troglitazone |
troglitazone results in decreased expression of TNFSF11 mRNA | decreases expression | 16813520
|
D009536 |
Niacinamide |
Niacinamide results in decreased expression of TNFSF11 mRNA | decreases expression | 16813520
|
D002762 |
Cholecalciferol |
Cholecalciferol promotes the reaction [[RXRB protein binds to VDR protein] which binds to TNFSF11 promoter] | affects binding|increases reaction | 17008384
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of TNFSF11 mRNA | increases expression | 17008384
|
D002762 |
Cholecalciferol |
decitabine promotes the reaction [Cholecalciferol results in increased expression of TNFSF11 mRNA] | increases expression|increases reaction | 17008384
|
D024482 |
Vitamin K 2 |
Vitamin K 2 results in decreased expression of TNFSF11 mRNA | decreases expression | 19675304
|
D024483 |
Vitamin K 3 |
Vitamin K 3 results in decreased expression of TNFSF11 mRNA | decreases expression | 19675304
|
C088658 |
zoledronic acid |
ADAM17 protein promotes the reaction [zoledronic acid results in decreased expression of TNFSF11 protein] | decreases expression|increases reaction | 14753746
|
C088658 |
zoledronic acid |
TAPI-2 inhibits the reaction [zoledronic acid results in decreased expression of TNFSF11 protein] | decreases expression|decreases reaction | 14753746
|
C088658 |
zoledronic acid |
zoledronic acid affects the expression of TNFSF11 protein | affects expression | 17041912
|
C088658 |
zoledronic acid |
zoledronic acid results in decreased expression of TNFSF11 protein | decreases expression | 14753746
|
D015054 |
Zymosan |
NCF1 protein affects the reaction [Zymosan affects the expression of TNFSF11 mRNA] | affects expression|affects reaction | 14507659
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.76 | 14514962 11752688 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
6.76 | 8333272 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.97 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
7.31 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
7.31 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.58 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
4.89 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
6.01 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.01 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
6.01 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
5.61 | 3712494 |
MESH:D000236 |
Adenoma |
|
resveratrol |
5.61 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
7.94 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
7.94 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.10 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
11.78 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
11.78 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.03 | 17308373 17451421 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.48 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.14 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
8.07 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
icariin |
8.07 | 19782061 19858766 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
8.07 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
8.07 | 16183991 16162502 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
3.96 | 16510725 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.28 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
7.28 | 18664788 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.71 | 17084956 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
4.25 | 18313124 11141031 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.60 | 17460149 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.67 | 18414634 16251483 12569548 16835338 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
18.94 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
18.94 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
18.94 | 9598899 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
18.94 | 16412693 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
18.94 | 15944321 15142272 15188379 16872482 17659584 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
4.13 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.13 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.14 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.38 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
12.69 | 19371607 12928151 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
12.69 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
quercetin 3-O-glucuronide |
12.69 | 18199750 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
12.69 | 16873680 17967414 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
14.84 | 16142846 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
14.84 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
14.84 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.84 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.41 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
17.59 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
17.59 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
17.59 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
17.59 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.19 | 15340226 |
MESH:D001847 |
Bone Diseases |
|
icariin |
5.81 | 18295595 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.36 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
4.56 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.41 | 16778634 19442620 11697798 16121404 15867366 17312309 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.17 | 18404659 15845617 16769263 8053405 11869084 18496637 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
3.96 | 15306635 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
3.90 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
13.84 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
icariin |
13.84 | 19303870 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
13.84 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.43 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
9.86 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
9.86 | 18593918 16243823 18462866 19250217 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
9.86 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
9.86 | 18497071 14630087 17289903 12948864 17018787 19861407 16675129 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
9.86 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
9.86 | 16541309 17200150 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
kaempferol |
9.86 | 16756079 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
9.86 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
9.86 | 17952589 15758505 17242785 17893378 16837676 15775269 17261762 15572757 16912660 17440819 17049068 17595753 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
9.86 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
9.86 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
9.86 | 16166294 16443354 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
9.86 | 18695136 16096432 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.00 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.78 | 11589617 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.94 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.87 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
6.71 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.71 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.23 | 15504454 17687452 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.55 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
25.93 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
25.93 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
25.93 | 16217749 15073043 14691202 11135700 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
25.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
25.93 | 15341023 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
25.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
25.93 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
25.93 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
25.93 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
25.93 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
25.93 | 1917145 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vitamin K 2 |
25.93 | 17270033 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.00 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
5.15 | 18414057 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
5.15 | 19233551 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.38 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.27 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
5.76 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
5.76 | 18507039 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.60 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
22.26 | 15504454 18922899 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
22.26 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
22.26 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
22.26 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
22.26 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
22.26 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
22.26 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
22.26 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
7.95 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
7.95 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
9.39 | 17124262 11179087 11754973 17287366 15728586 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
9.39 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
9.39 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
18.24 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
18.24 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
kaempferol |
18.24 | 16756079 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
18.24 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
18.24 | 15458977 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.80 | 16973168 18022660 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.72 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
8.75 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
8.75 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
8.75 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.00 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.09 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
8.09 | 18291259 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
15.73 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Diosgenin |
15.73 | 16105132 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
15.73 | 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
15.73 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.55 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.81 | 8697196 15340226 16354765 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.81 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.04 | 15800139 |
MESH:D003092 |
Colitis |
|
Curcumin |
18.18 | 18200517 16804969 16782535 |
MESH:D003092 |
Colitis |
|
resveratrol |
18.18 | 16474422 |
MESH:D003092 |
Colitis |
|
Thalidomide |
18.18 | 16680017 |
MESH:D003092 |
Colitis |
|
Tretinoin |
18.18 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.02 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
14.95 | 16340194 19359593 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
14.95 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
14.95 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
14.95 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
14.95 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
14.95 | 19440933 17191121 16640504 19056647 15741050 17148506 11134977 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
14.95 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
4.18 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.18 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
4.18 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.18 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.56 | 14669216 17141729 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
10.68 | 18497527 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
10.68 | 9301478 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.35 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.62 | 12609071 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
5.70 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.36 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
6.36 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.36 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
6.36 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.36 | 9224671 17551590 9211117 8800419 14991402 9125849 9664655 16925845 9142499 10589399 |
MESH:D016638 |
Critical Illness |
|
Estrogens |
5.35 | 16670151 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
3.85 | 16078585 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.55 | 15213294 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.66 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
5.18 | 14531868 11298694 11906362 2524372 18759878 8970840 8156756 12868966 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
5.18 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.12 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.95 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
exenatide |
11.44 | 19586609 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
11.44 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
11.44 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
14.79 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
exenatide |
14.79 | 19586609 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
14.79 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Niacinamide |
14.79 | 19647726 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
14.79 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
troglitazone |
14.79 | 16023994 |
MESH:D003925 |
Diabetic Angiopathies |
|
troglitazone |
5.06 | 12601628 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
17.34 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
17.34 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
17.34 | 17308373 15920148 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
17.34 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.15 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
9.74 | 7440962 1440618 6679447 16192314 18289764 18648102 9328219 6482804 9653073 9022650 11289319 8291058 18692083 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
9.74 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Prazosin |
9.74 | 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.74 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
troglitazone |
9.74 | 14986274 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.31 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.49 | 17351913 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
4.34 | 16935035 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.90 | 12438553 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
33.69 | 8273558 |
MESH:D004487 |
Edema |
|
Dexamethasone |
33.69 | 19703484 |
MESH:D004487 |
Edema |
|
Furosemide |
33.69 | 11834646 |
MESH:D004487 |
Edema |
|
pirinixic acid |
33.69 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
33.69 | 15860553 |
MESH:D004487 |
Edema |
|
resveratrol |
33.69 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
33.69 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
33.69 | 15177302 7812673 9599246 8113982 8273558 16716910 11698051 |
MESH:D004487 |
Edema |
|
Zymosan |
33.69 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.94 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.94 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
12.28 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
12.28 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
12.28 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.51 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.00 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
10.10 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
10.10 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
10.10 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.51 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.27 | 17923197 |
MESH:D007172 |
Erectile Dysfunction |
|
icariin |
4.87 | 16281085 15329286 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.84 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
3.84 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.33 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.33 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
14.49 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
14.49 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.49 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
14.49 | 17473493 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.23 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.88 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.41 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
16.48 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
16.48 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.48 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
16.48 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
4.95 | 6392382 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.70 | 16904648 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.12 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.09 | 16452187 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
5.70 | 12701121 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
13.63 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
13.63 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
13.63 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
13.63 | 17312396 |
MESH:D005910 |
Glioma |
|
Quercetin |
5.62 | 17643826 |
MESH:D005910 |
Glioma |
|
Thalidomide |
5.62 | 16327979 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.49 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.99 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
10.58 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
10.58 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
10.58 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.32 | 17868369 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.55 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.39 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.39 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.11 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
6.02 | 16845234 12660669 16011733 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.02 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.80 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
7.77 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
7.77 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.36 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.36 | 12621046 15340226 16120746 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.46 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.83 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.43 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Amsacrine |
13.29 | 10809021 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
13.29 | 10809021 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
13.29 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
6.00 | 15147373 17606976 18180244 16135485 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.00 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.15 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.44 | 15340226 16354765 8697196 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Prazosin |
10.69 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
10.69 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
10.69 | 16769263 |
MESH:D006934 |
Hypercalcemia |
marker/mechanism |
|
| 15845617 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
9.53 | 17652376 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
9.53 | 19622757 18089816 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.06 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
7.62 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
7.62 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.99 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
kaempferol |
18.25 | 18262572 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
18.25 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
18.25 | 18262572 11834736 |
MESH:D006943 |
Hyperglycemia |
|
triphenyltin |
18.25 | 10522495 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
3.94 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.49 | 16873680 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.27 | 15086907 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.36 | 15034207 |
MESH:D006973 |
Hypertension |
|
Arsenic |
17.15 | 9931084 16076760 11953799 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
17.15 | 17042910 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
17.15 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Quercetin |
17.15 | 18356687 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
17.15 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
17.15 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
4.71 | 16612254 |
MESH:D015228 |
Hypertriglyceridemia |
|
triphenyltin |
5.44 | 10522495 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.02 | 12791704 18502941 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.78 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
4.95 | 16093927 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.59 | 12669777 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.06 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.27 | 16096441 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.08 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
4.81 | 15811171 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.07 | 17600658 |
MESH:D007246 |
Infertility |
|
triphenyltin |
5.46 | 15205045 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
5.53 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.53 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
26.42 | 8273558 |
MESH:D007249 |
Inflammation |
|
Curcumin |
26.42 | 16956363 18403477 17151092 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
26.42 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
polyphenols |
26.42 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
26.42 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
26.42 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
26.42 | 15177302 7812673 8273558 7562506 11698051 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
26.42 | 16134734 |
MESH:D007249 |
Inflammation |
|
Zymosan |
26.42 | 8014878 11289658 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.94 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
9.19 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.19 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
10.23 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
exenatide |
10.23 | 19586609 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
10.23 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.19 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.70 | 10783313 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.24 | 17553498 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.41 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.16 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.16 | 17551590 15992940 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.38 | 17086741 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.40 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
11.49 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
11.49 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
11.49 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
11.49 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.75 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
5.75 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
icariin |
4.75 | 19782061 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
9.33 | 18555241 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
9.33 | 16973256 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
3.88 | 16514283 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
24.71 | 15070760 |
MESH:D007938 |
Leukemia |
|
Curcumin |
24.71 | 18462866 |
MESH:D007938 |
Leukemia |
|
decitabine |
24.71 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Genistein |
24.71 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
kaempferol |
24.71 | 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
24.71 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
24.71 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
troglitazone |
5.54 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
marker/mechanism |
|
| 16270354 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
13.30 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
13.30 | 16106398 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
13.30 | 18089816 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
9.76 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
9.76 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.98 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
12.93 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
12.93 | 19117987 17236224 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
12.93 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Amsacrine |
10.14 | 15148258 18043129 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
10.14 | 20471514 16467208 17050201 16968895 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
10.14 | 18206229 17679729 19387464 18460780 19010910 18704418 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
10.14 | 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
10.14 | 19850784 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.86 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
14.84 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
14.84 | 17869043 17712046 15622746 12018890 16891316 15336539 17217047 12712474 11161223 16823087 15213294 17107899 16966277 16330433 19225113 9834237 12679006 11468182 17649720 16112521 19075265 15748426 16331271 19035177 19642359 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
14.84 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
14.84 | 9834237 19029980 17217047 17506722 17339181 16331271 17649720 16935935 17107899 12679006 17712046 17301526 16891316 19225113 15748426 17361223 16823087 19075265 17294898 16788101 19035177 16766008 19642359 17368321 16140955 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
9.84 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
9.84 | 16106398 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
7.09 | 10473037 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
7.09 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
3.66 | 17174718 16943688 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.80 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
13.61 | 17355460 18006644 18705752 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
13.61 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
13.61 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
13.61 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
13.61 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
13.61 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
13.61 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
13.61 | 15465738 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
13.61 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
5.62 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
5.62 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
5.62 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
17.81 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
17.81 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
17.81 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
17.81 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
17.81 | 19321006 19812893 20405173 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
17.81 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.81 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
10.90 | 3712494 1399818 6587162 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
10.90 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
10.90 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.90 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.89 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.76 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
11.17 | 17976673 17306315 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
11.17 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
11.17 | 16243823 19359593 18462866 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
11.17 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
11.17 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
11.17 | 15276417 16712894 17077188 17306315 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
11.17 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
11.17 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
10.18 | 18462866 |
MESH:D008223 |
Lymphoma |
|
decitabine |
10.18 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
10.18 | 12556972 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.75 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.38 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.12 | 16173963 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.66 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
18.39 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
18.39 | 11408345 17203775 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
18.39 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
18.39 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
18.39 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
18.39 | 17312309 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.88 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.52 | 17453147 |
MESH:D008545 |
Melanoma |
|
Curcumin |
13.19 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
decitabine |
13.19 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
resveratrol |
13.19 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
13.19 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
13.19 | 12829675 16098027 17089043 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
13.19 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vitamin K 3 |
13.19 | 19082730 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
8.30 | 17263510 |
MESH:D008569 |
Memory Disorders |
|
icariin |
8.30 | 19782061 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.85 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.48 | 16675582 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.84 | 17112576 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
4.95 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
32.29 | 14977855 19549372 15949261 11468182 19417148 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
32.29 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
32.29 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
32.29 | 15867202 15744524 16118317 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
32.29 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
32.29 | 17049120 16267019 16490592 17164350 14749477 17935668 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
32.29 | 19372569 15939924 16445831 19112201 15741222 17168659 19112817 15867202 15920492 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
32.29 | 19621390 18089719 16996129 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.66 | 15259001 12879239 15834315 15241586 17724436 18160304 12130978 15213630 10890648 10479408 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
10.45 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
10.45 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.93 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.07 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
19.20 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
19.20 | 19157545 19010910 18608210 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
19.20 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
19.20 | 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
19.20 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
11.22 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
11.22 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
11.22 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
11.22 | 16317513 17188708 17015251 16456233 17125593 16525036 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
12.54 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
12.54 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
12.54 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.49 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
16.49 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
16.49 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
16.49 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.17 | 17322642 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
4.95 | 16343187 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
8.46 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
8.46 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.18 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
5.18 | 15867366 19139120 17312309 |
MESH:D009369 |
Neoplasms |
|
decitabine |
12.25 | 17925555 19470736 19116145 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
12.25 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
12.25 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
12.25 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
12.25 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.32 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.32 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
3.93 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.14 | 17289903 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.27 | 15086907 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
24.82 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
24.82 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
24.82 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
24.82 | 16859833 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
24.82 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.03 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
18.45 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
18.45 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
18.45 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
18.45 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
18.45 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.32 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
14.65 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
14.65 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
14.65 | 17929310 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.27 | 17945291 |
MESH:D009765 |
Obesity |
|
Curcumin |
3.98 | 19297423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.98 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
2.91 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.41 | 3988306 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
4.78 | 15867366 |
MESH:D010022 |
Osteopetrosis |
marker/mechanism |
|
| 17632511 |
OMIM:259710 |
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2 |
marker/mechanism |
|
| |
MESH:D010024 |
Osteoporosis |
therapeutic |
|
| 17882678 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
37.44 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
exenatide |
37.44 | 19586609 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
37.44 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
icariin |
37.44 | 19747809 18236786 |
MESH:D010024 |
Osteoporosis |
|
kaempferol |
37.44 | 16756079 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
37.44 | 12665316 |
MESH:D010024 |
Osteoporosis |
|
nylestriol |
37.44 | 12665316 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
37.44 | 19059307 17882678 15775268 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
37.44 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
19.55 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
19.55 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
19.55 | 15579764 17893378 17823083 15758505 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
19.55 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
30.90 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
30.90 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
30.90 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
30.90 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
30.90 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
30.90 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
30.90 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
30.90 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
30.90 | 16288038 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
30.90 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.57 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
5.57 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
20.97 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
20.97 | 17440100 19196508 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
20.97 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
20.97 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
20.97 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
20.97 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
20.97 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
7.48 | 7296757 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
7.48 | 18922899 12065085 18404319 8330346 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.61 | 19927285 |
MESH:D010291 |
Paresis |
|
Thalidomide |
5.70 | 9200351 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.64 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Niacinamide |
5.84 | 11026799 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.62 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.40 | 15371236 6392382 16905509 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.31 | 18977430 15259001 19641140 15979727 18557954 18760300 17826846 17371808 11985352 14761945 19088179 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.87 | 6228378 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.06 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.00 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
3.48 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
6.77 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
6.77 | 17031469 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
7.63 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.63 | 11118676 11222880 11896295 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.15 | 17616702 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.19 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.35 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
6.15 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
6.15 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
6.15 | 18247401 16644109 15754350 12479363 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
6.15 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
6.15 | 12497104 10851300 15129424 18769126 18156803 11398177 18226269 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
6.15 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
6.15 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
6.15 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
6.15 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
6.15 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
6.15 | 17675339 17718901 17804756 16731767 17636462 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
6.15 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
6.15 | 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
6.15 | 19103299 12438248 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
7.47 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
7.47 | 16636307 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
5.70 | 12755975 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
4.80 | 15861022 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.20 | 16723453 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.01 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
troglitazone |
3.64 | 18162602 |
MESH:D011693 |
Purpura |
|
Raloxifene |
4.95 | 15770314 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.43 | 10930210 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.98 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
9.17 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
9.17 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
9.17 | 15827377 17520802 17058453 16314181 16317513 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
12.20 | 18379247 10666014 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
12.20 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
12.20 | 15912074 12394941 16096441 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.92 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.13 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.13 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.60 | 18462866 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
14.17 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
14.17 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
14.17 | 16121404 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.94 | 16862918 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.35 | 16096327 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
3.50 | 10087439 9754883 |
MESH:D018805 |
Sepsis |
|
Curcumin |
8.06 | 18389075 |
MESH:D018805 |
Sepsis |
|
Zymosan |
8.06 | 11441115 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.11 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.57 | 19834688 17548696 16702368 17453740 6392382 16353154 16759981 15952646 17050553 17938729 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
18.40 | 17029826 16251483 17050553 19538983 15504454 17976673 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
18.40 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
18.40 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
18.40 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
18.40 | 12065085 11807781 8985016 18404319 8330346 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
18.40 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.33 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.73 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
5.54 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
5.54 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
5.54 | 17052386 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
5.54 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
troglitazone |
5.54 | 15930296 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
9.24 | 16631530 19188055 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
9.24 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
9.24 | 15138204 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.35 | 16837676 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.96 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
4.46 | 9754883 11529278 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
4.65 | 17997062 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.30 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
13.34 | 1399818 3712494 6587162 7505956 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
13.34 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
13.34 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
13.34 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
11.70 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
11.70 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.19 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.19 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.37 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.84 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
23.73 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
23.73 | 17976673 17306315 15987713 11144890 19429237 19322015 18640142 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
23.73 | 12845720 20435036 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
23.73 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
23.73 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
23.73 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
23.73 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
23.73 | 11723127 17306315 16712894 16452187 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.67 | 18462866 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
12.90 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
12.90 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
12.90 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.58 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
10.82 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
10.82 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
10.28 | 1336536 |
MESH:D014605 |
Uveitis |
|
Zymosan |
10.28 | 11006244 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
16.83 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
16.83 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
16.83 | 15741222 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.99 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.60 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
5.08 | 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.73 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.49 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
4.95 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.64 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.46 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
4.25 | 11172683 |